Lei H. Miao
No. 9 Jinsui Road
Guangzhou, 510623, China
Guangzhou, 510623, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Single-cell transcriptomic atlas-guided NRG3-ERBB4 axis enhances the efficacy of chemo-immunotherapy during induction phase in high-risk neuroblastoma.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: November 04, 2025
Integrated transcriptomics unveils mitochondrial oxidative phosphorylation dysfunction as a shared mechanism in sarcopenia and obesity.
Journal: Scientific reports
Published: June 14, 2025
Mechanism of DKK3 protecting brain tissues in ischemic stroke by regulating LGI1 expression and activity.
Journal: European journal of medical research
Published: March 22, 2025
Identification and validation of cellular senescence-related genes and immune cell infiltration characteristics in intervertebral disc degeneration.
Journal: Frontiers in immunology
Published: March 08, 2025
Degradation of IRF6 by TRIM59 in tumor cells triggers PGM1-mediated glycolysis to regulate cell proliferation in neuroblastoma.
Journal: Cell death & disease
Published: January 02, 2025
EDF1 accelerates ganglioside GD3 accumulation to boost CD52-mediated CD8+ T cell dysfunction in neuroblastoma.
Journal: Journal of experimental & clinical cancer research : CR
Published: October 21, 2024
Neuroblastoma risk decreased by NSUN3 rs7653521 C>T polymorphism in Chinese children.
Journal: Chinese medical journal
Published: September 12, 2024
S-Propargyl-Cysteine Attenuates Stroke Heterogeneity via Promoting Protective Autophagy Across Multiple Neural Cell Types: Insights From Single-Cell Sequencing.
Journal: CNS neuroscience & therapeutics
Published: June 18, 2024
Predictive value of glycoprotein DKK3 for early neurological deterioration after ischemic stroke.
Journal: Clinics (Sao Paulo, Brazil)
Published: November 06, 2023
MUC15 is an independent prognostic factor that promotes metastases of MYCN non-amplified neuroblastoma.
Journal: Journal of Cancer
Published: August 21, 2023
Cross-cohort analysis identified an immune checkpoint-based signature to predict the clinical outcomes of neuroblastoma.
Journal: Journal for immunotherapy of cancer
Published: April 16, 2023
Last Updated: 09/26/2026